Skip to main navigation

Skip to Content

Skip to Content

Investors & Media Contact Us LinkedIn Twitter

About Us
Our Focus
- Schizophrenia
- Psychosis in Alzheimer’s Disease
Pipeline & Programs
Patient Resources
Culture & Careers

SEC Filing Details

Overview
Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Information
Investor Resources
Media Kit

SEC Filing Details

Document Details

Form

Filing Date

May 21, 2019

Document Date

May 21, 2019

Form Description

UPLOAD

Filing Group

Other

Company

Karuna Therapeutics

Issuer

Karuna Therapeutics, Inc.

Filing Formats

View HTML

Print Page Email Page RSS Feeds Email Alerts

About Us
Our Focus
Pipeline & Programs
Patient Resources
Culture & Careers
Investors & Media
Contact Us

Connect with us on LinkedIn Twitter

Copyright 2022 Karuna Therapeutics™. All Rights Reserved. Privacy Policy. Terms of Use. Top

Top